Anti-infective vaccination strategies in patients with hematologic malignancies or solid tumors-Guideline of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO)
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Annals of Oncology 29: 1354–1365, 2018
- Ereignis
-
Veröffentlichung
- (wo)
-
Würzburg
- (wer)
-
Universität Würzburg
- (wann)
-
2021
- Urheber
-
Rieger, C. T.
Liss, B.
Mellinghoff, S.
Buchheidt, Dieter
Cornely, O. A.
Egerer, Gerlinde
Heinz, W. J.
Hentrich, M.
Maschmeyer, G.
Mayer, K.
Sandherr, M.
Silling, G.
Ullmann, A.
Vehreschild, M. J. G. T.
von Lilienfeld-Toal, M.
Wolf, H. H.
Giesen, Nicola
- DOI
-
10.1093/annonc/mdy117
- URN
-
urn:nbn:de:bvb:20-opus-226196
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 05:36 UTC
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Rieger, C. T.
- Liss, B.
- Mellinghoff, S.
- Buchheidt, Dieter
- Cornely, O. A.
- Egerer, Gerlinde
- Heinz, W. J.
- Hentrich, M.
- Maschmeyer, G.
- Mayer, K.
- Sandherr, M.
- Silling, G.
- Ullmann, A.
- Vehreschild, M. J. G. T.
- von Lilienfeld-Toal, M.
- Wolf, H. H.
- Giesen, Nicola
- Universität Würzburg
Entstanden
- 2021
Ähnliche Objekte (12)
Hematologic malignancies
Anti-infective vaccination strategies in patients with hematologic malignancies or solid tumors-Guideline of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO)
Hematologic malignancies : acute leukemias ; with 51 tables
COVID-19 in Hematologic Malignancies: Big Challenges
Targeting CD22 for B-cell hematologic malignancies
Biomimetic Nanoparticles for the Treatment of Hematologic Malignancies
Biological relevance of alternative splicing in hematologic malignancies
Genomic testing for germline predisposition to hematologic malignancies
Antifungal Stewardship Interventions in Patients with Hematologic Malignancies
CAR-T cell combination therapies in hematologic malignancies
Immunotherapy in hematologic malignancies: past, present, and future
Therapeutic dendritic cell cancer vaccines in hematologic malignancies
Hematologic malignancies
Anti-infective vaccination strategies in patients with hematologic malignancies or solid tumors-Guideline of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO)
Hematologic malignancies : acute leukemias ; with 51 tables
COVID-19 in Hematologic Malignancies: Big Challenges
Targeting CD22 for B-cell hematologic malignancies
Biomimetic Nanoparticles for the Treatment of Hematologic Malignancies
Biological relevance of alternative splicing in hematologic malignancies
Genomic testing for germline predisposition to hematologic malignancies
Antifungal Stewardship Interventions in Patients with Hematologic Malignancies
CAR-T cell combination therapies in hematologic malignancies
Immunotherapy in hematologic malignancies: past, present, and future
Therapeutic dendritic cell cancer vaccines in hematologic malignancies
Hematologic malignancies
Anti-infective vaccination strategies in patients with hematologic malignancies or solid tumors-Guideline of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO)
Hematologic malignancies : acute leukemias ; with 51 tables
COVID-19 in Hematologic Malignancies: Big Challenges
Targeting CD22 for B-cell hematologic malignancies
Biomimetic Nanoparticles for the Treatment of Hematologic Malignancies
Biological relevance of alternative splicing in hematologic malignancies
Genomic testing for germline predisposition to hematologic malignancies
Antifungal Stewardship Interventions in Patients with Hematologic Malignancies
CAR-T cell combination therapies in hematologic malignancies
Immunotherapy in hematologic malignancies: past, present, and future